Table 6 Visual Acuity Follow-up
From: Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series
Injection Group | Better Vision PPV Group | Worse Vision PPV Group | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 |
VA before infection | 20/400 | 20/80 | 20/400 | 20/40 | HM | 20/63 | 20/50 | CF | 20/100 | 20/200 | 20/100 | CF | 20/400 | 20/30 | 20/200 | 20/32 | No data | 20/40 | CF | HM | CF | No data | HM |
VA right before treatment | CF | CF | CF | LP | LP | 20/63 | 20/160 | CF | CF | CF | HM | HM | HM | HM | HM | LP | LP | LP | LP | LP | LP | LP | LP |
VA after 1 year of treatment | 20/80 | 20/200 | CF | 20/100 | NLP | 20/100 | CF | CF | 20/70 | 20/200 | 20/200 | 20/200 | 20/400 | 20/100 | 20/80 | LP | 20/400 | HM | 20/125 | NLP | NLP | NLP | NLP |